Niagen Bioscience Stock (NASDAQ:NAGE)
Previous Close
$5.22
52W Range
$4.73 - $14.69
50D Avg
$5.69
200D Avg
$8.39
Market Cap
$391.59M
Avg Vol (3M)
$1.14M
Beta
2.23
Div Yield
-
NAGE Company Profile
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
NAGE Performance
Peer Comparison
| Ticker | Company |
|---|---|
| KALV | KalVista Pharmaceuticals, Inc. |
| RGNX | REGENXBIO Inc. |
| RIGL | Rigel Pharmaceuticals, Inc. |
| PRTA | Prothena Corporation plc |
| AKBA | Akebia Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| KROS | Keros Therapeutics, Inc. |
| OLMA | Olema Pharmaceuticals, Inc. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| ZVRA | Zevra Therapeutics, Inc. |